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76* The bacterial burden of the CF lung – Uncovering the black box
T. Bjarnsholt2, P.O. Jensen1, K. Madsen3, C.B. Andersen1, T. Pressler1,
M. Givskov2, N. Høiby1. 1Rigshospitalet, Copenhagen, Denmark; 2DTU, Lyngby,
Denmark; 3AdvanDx, DK, Denmark
Lately chronic bacterial infections have more or less become a synonym with
bioﬁlm infections, at least in theory. Especially Cystic ﬁbrosis (CF) lungs which
are chronically infected with bacteria have been intensively studied.
The present study was performed to shed light on how P. aeruginosa is organized
and persists in the CF lung. The material used were: autopsies from dead short term
colonized CF patients (n = 12) and explanted lungs from long term P. aeruginosa
infected CF patients (n = 4). Histological sections of the lungs were investigated
using HE stain, Gram stain, alcian blue and P. aeruginosa speciﬁc PNA-FISH
combined with BacUni PNA-FISH and with DAPI as counter stains.
Due to the high speciﬁcity of the PNA-FISH probes employed in this study, our
results provide strong evidence for that P. aeruginosa is located in the conductive
zone (bronchi and sputum) and in the respiratory zone (respiratory bronchioles and
alveoli). Here the bacteria are organized in microcolonies imbedded in puss, a trait
which is independent on the time course of the infection and amounts of antibiotics.
These microcolonies consisted solely of P. aeruginosa in a matrix containing non-
host polysaccharides. In addition, we found no bacteria adhering to the epithelial
tissue. The puss consisted mainly of leukocytes, surrounding the microcolonies. A
smear of DNA and dead leukocytes were detected just around the microcolonies,
possible due to the QS dependent rhamnolipid killing recently described by us
(Jensen et al. 2006).
We conclude that P. aeruginosa persists in the CF lung due to its ability of forming
microcolonies protected with a matrix of polysaccharides i.e. bioﬁlms. Within these
bioﬁlms the bacteria are protected against antibiotics and the host defence.
77* Impact of reducing routine sensitivity testing in chronic
Pseudomonas aeruginosa infections in cystic ﬁbrosis
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Susceptibility testing results are not predictive of clinical response to antibiotic
therapy in chronic Pseudomonas aeruginosa infections in cystic ﬁbrosis. We
assessed the impact of reducing the number of routine susceptibility tests performed
on clinical outome in these cases. In June 2006 we introduced a protocol of limiting
susceptibility tests to P. aeruginosa isolates obtained from respiratory samples taken
at the commencement of antibiotic therapy, when there was evidence of clinical
failure, or routinely if not tested in the previous three months. At all other times,
isolates were identiﬁed and reported as normal but P. aeruginosa isolates were
not subjected to susceptibility tests. Between 1st June and 30th November 2006
P. aeruginosa, was isolated on at least one occasion from 193 patients attending
our Adult CF Unit. In this six month period we reduced the number of susceptibility
tests by 56% (from a projected 2,231 tests on 872 samples to an actual 972 tests
on 427 samples). This resulted in projected savings of €3,500 in consumables and
170 hours (costed at €6,500) of laboratory staff time per annum, a total saving of
€10,000 (£6,500) per annum. We assessed the response to intravenous antibiotic
treatment between the study period in 2006 and the same period in 2005. No
signiﬁcant differences in median change of FEV1, FVC, CRP, white cell count,
weight, or duration of intravenous antibiotics were observed. For CF units sending
regular, routine sputum samples, a reduction in the number of susceptibility tests
performed in cases of chronic P. aeruginosa can be carried out without impacting
on clinical outcomes.
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The aim of the study was to determine and compare pathogen prevalence in CF
patients and to assess antibiotic susceptibility of P. aeruginosa (Pa), S. aureus (Sa)
and H. inﬂuenzae (Hi).
Material: The CF pts with gastroenterological diseases (billiary cirrhosis, oesophageal
varices, malnutriton) were examined. Spontaneus sputum samples (ss) and orophar-
ingeal swabs (os) were analysed. Identiﬁcation and susceptibility testing of strains were
performed by use of standard methods. From 1999–2002 254 os and 157 ss were taken
from 58 pts. From 2003–2006 306 os and 98 ss were taken from 76 pts. We examined
Sa susceptibility to oxacyllin, erythromycin, clindamycin, tetracycline, gentamycin,
rifampicin, co-trimoxazole, vancomycin, ciproﬂoxacin, Hi susceptibility to ampicyllin,
amoxicillin/clavulanic acid, cefaclor, cefuroxime, co-trimoxazole, azitromycin, clar-
ithromycin and Pa susceptibility to imipenem, ceftazidime, ticarcillin/clavulanic acid,
piperacillin, piperacillin/tazobactam, gentamycin, ciproﬂoxacin.
Conclusions: Our study conﬁrmes typical for CF pts colonization with Sa, Hi and Pa.
During the 7-year period only Hi prevalence increased from 17% to 26%. Chemother-
apeutic susceptibility didn’t change apart from Pa susceptibility to piperacillin, which
decreased by 24%.
Isolated pathogens Years 1999–2002 Years 2003–2006
No. of isolates % No. of isolates %
S. aureus 181 48 288 44
H. inﬂuenzae 65 17 173 26
P. aeruginosa 52 13 91 14
79 Bacterial contamination of PEP masks
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Chest physiotherapy with the use of a positive expiratory pressure (PEP) mask
is widely used in patients with CF. Given the widespread use of PEP devices
there is a need to evaluate hygienic measures taken to minimize their bacterial
contamination. At Stockholm CF centre we recommend dismantling the PEP-mask,
washing, rinsing and drying once a day and disinfecting it twice a week (daily when
the patient is infected) by boiling water or by 2% acetic acid followed by drying
without rinsing.
Aim of study: to investigate whether these prescribed routines are followed by our
patients and whether they are sufﬁcient to prevent bacterial contamination.
Methods: 47 PEP-masks (188 pieces) from 37 patients (mean age 20 (5−46) y,
73% chronically colonized with P. aeruginosa) were investigated. 35 patients were
visited at home. Swabs were taken from all pieces and quantitatively cultured on
four different media.
Results: Twenty-three (49%) of the 47 PEP-masks were cleaned/disinfected ac-
cording to our recommendations. The most common failure was not having dried
the pieces. 16/47 of the PEP masks (145/188 pieces) showed no or scanty growth
of microorganisms belonging to the normal pharyngeal ﬂora. 14 pieces revealed
growth of S. aureus, 11 of Pseudomonas species. There was less growth on the
Laerdal mask compared to the conventional mask.
Conclusion: Our prescribed routines were not sufﬁciently followed but adequate
when they were. Home visits are recommended.
